COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS ON THE USE OF CHLORHEXIDINE GLUCONATE SPONGE TO PREVENT INFECTIONS RELATED TO CENTRAL VENOUS CATHETER IN COLOMBIA

被引：0
|
作者：
Gamboa, O. [1 ]
Gil, A. M. [1 ]
Lozano, T. [1 ]
Leon, E. [1 ]
Gamboa, C. [1 ]
Fuentes, J. C. [1 ]
Andrade, P. C. [2 ]
Cabra, H. A. [3 ]
CortesCortes, J. [4 ]
机构：
[1] IECAS, Bogota, Colombia
[2] Johnson & Johnson Med, Bogota, Colombia
[3] Johnson & Johnson Med, Mexico City, DF, Mexico
[4] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.700
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD23
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [41] Early prophylaxis of central venous catheter-related thrombosis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings: a retrospective cohort study
    Yamashita, Tomoko
    Takamori, Ayako
    Nakagawachi, Akira
    Tanigawa, Yoshinori
    Hamada, Yohei
    Aoki, Yosuke
    Sakaguchi, Yoshiro
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] Clinical and Cost Effectiveness of Guidelines To Prevent Intravascular Catheter-Related Infections in Patients on Hemodialysis
    Bakke, Christine K.
    NEPHROLOGY NURSING JOURNAL, 2010, 37 (06) : 601 - 616
  • [43] Venous stenting for patients with outflow obstruction and leg ulcers: cost-effectiveness and budget impact analyses
    Rognoni, Carla
    Lugli, Marzia
    Maleti, Oscar
    Tarricone, Rosanna
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (10) : 705 - 720
  • [44] Use of 4% tetrasodium EDTA (KiteLock™) to prevent central venous catheter-related bloodstream infections in pediatric hemodialysis patients
    Robinson, Cal H.
    Harvey, Elizabeth
    Nemec, Rose
    Karkut, Katherine
    Tecson, Lor
    Mckay, Ashlene M.
    PEDIATRIC NEPHROLOGY, 2025, 40 (04) : 1081 - 1091
  • [45] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA
    Diaz-Sotelo, O. D.
    Barbosa Castro, T.
    Ortiz, Vecino A.
    Quevedo, Mould J. F.
    Vargas Zea, N.
    Prieto Martinez, V
    VALUE IN HEALTH, 2013, 16 (03) : A92 - A92
  • [46] Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis
    Toelle, Daniela
    Hentrich, Marcus
    Pelzer, Benedikt W.
    Kremer, Pierre
    Einhell, Sabine
    Schulz, Sebastian
    Boell, Boris
    Panse, Jens
    Schmidt-Hieber, Martin
    Teschner, Daniel
    Schalk, Enrico
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (10): : 1204 - 1206
  • [47] The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis
    Huang, E.
    Esrailian, E.
    Spiegel, B. M. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (08) : 1147 - 1161
  • [48] Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism
    Coleman, Craig I.
    Limone, Brendan L.
    Bookhart, Brahim K.
    Mody, Samir H.
    Nutescu, Edith A.
    THROMBOSIS RESEARCH, 2014, 133 (05) : 743 - 749
  • [49] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS
    Cortesi, P. A.
    Castaman, G.
    Trifiro, G.
    Ferrario, M.
    Improta, G.
    Mazzaglia, G.
    Molinari, A. C.
    Mantovani, L. G.
    VALUE IN HEALTH, 2019, 22 : S845 - S845
  • [50] A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
    Capri, Stefano
    Migliore, A.
    Loconsole, F.
    Barbieri, Marco
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 353 - 361
12345